483 Dendreon Pharmaceuticals Jan 2018

483 Dendreon Pharmaceuticals Jan 2018

Mihaly Ligmond FDA, Arie Menachem FDA$119.00 - Available Now

FDA investigators audited the Dendreon Pharmaceuticals - Seal Beach, CA, United States facility and issued inspectional observations (via FDA 483) on 19 Jan 2018.

Product details

  • Category: Biologics
  • Inspection end: 19 Jan 2018
  • Location: Seal Beach, United States
  • FEI: 3008821247
Add To Cart